PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANAGlobeNewsWire • 04/08/24
SmallCapVoice.com Inc. (“SCV”) to Host First Annual Safety Summit featuring Up-and-Coming Public CompaniesGlobeNewsWire • 03/14/24
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, CaliforniaGlobeNewsWire • 02/29/24
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ TechnolgoyGlobeNewsWire • 02/07/24
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024GlobeNewsWire • 02/06/24
PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent ApplicationGlobeNewsWire • 01/23/24
PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDAGlobeNewsWire • 01/09/24
PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%MCAP MediaWire • 12/22/23
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH COVETRUS NORTH AMERICA, LLCGlobeNewsWire • 12/22/23
PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023GlobeNewsWire • 12/21/23
PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 StatesGlobeNewsWire • 12/11/23
PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, CaliforniaGlobeNewsWire • 11/21/23
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2023GlobeNewsWire • 11/09/23
PetVivo Holdings, Inc. Announces Presentation of Clinical Study Results at the American College of Veterinary Surgeons Conference in Louisville, KentuckyGlobeNewsWire • 10/12/23
PetVivo Holdings, Inc. Achieves National Distribution of Spryng to More than 500 Veterinary Clinics in 49 StatesGlobeNewsWire • 08/28/23